* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Industri Jamu dan Farmasi Sido Muncul Tbk ROE % Adjusted to Book Value Chart
PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
ISX:SIDO vs KHC, GIS: ROE % Adjusted to Book Value Comparison
For the Packaged Foods subindustry, PT Industri Jamu dan Farmasi Sido Muncul Tbk's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Industri Jamu dan Farmasi Sido Muncul Tbk ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PT Industri Jamu dan Farmasi Sido Muncul Tbk's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where PT Industri Jamu dan Farmasi Sido Muncul Tbk's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 3.97% mean?
PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) has a ROE % Adjusted to Book Value of 3.97% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk's ROE % Adjusted to Book Value too high?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's current ROE % Adjusted to Book Value is 3.97%. Overall, PT Industri Jamu dan Farmasi Sido Muncul Tbk has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Industri Jamu dan Farmasi Sido Muncul Tbk's ROE % Adjusted to Book Value compare to KHC and GIS?
PT Industri Jamu dan Farmasi Sido Muncul Tbk's ROE % Adjusted to Book Value of 3.97% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on PT Industri Jamu dan Farmasi Sido Muncul Tbk and its competitors. PT Industri Jamu dan Farmasi Sido Muncul Tbk's current ROE % Adjusted to Book Value is 3.97%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp607.07, compared to a current price of Rp380.00 — trading 37.4% below its estimated fair value. The current ROE % Adjusted to Book Value is 3.97%. PT Industri Jamu dan Farmasi Sido Muncul Tbk's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO), the current ROE % Adjusted to Book Value is 3.97% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Overvalued in 2026?
Based on GuruFocus' analysis, PT Industri Jamu dan Farmasi Sido Muncul Tbk stock appears to be undervalued.
The current stock price of Rp380.00 is trading 37.4% below its estimated GF Value™ of Rp607.07.
GuruFocus considers PT Industri Jamu dan Farmasi Sido Muncul Tbk to be Significantly Undervalued.
Key valuation signals for ISX:SIDO:
ROE % Adjusted to Book Value: 3.97%
GF Value™: Rp607.07 vs. price of Rp380.00 (37.4% below fair value)
No single metric tells the full story. See the ISX:SIDO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Industri Jamu dan Farmasi Sido Muncul Tbk Business Description
PT Industri Jamu dan Farmasi Sido Muncul Tbk is focused on the herbal medicine and herbal products industry, with its products categorized into three distinct segments: Herbal Medicine and Supplements, Food and Beverages, and Pharmaceuticals. Its flagship herbal products include Tolak Angin, available in variants such as Tolak Angin Cair, Tolak Angin Cair Anak, Tolak Angin Sugar Free, Tolak Angin Batuk, and Tolak Angin Flu. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionery products. The Pharmacy segment sells pharmaceutical products, including Anacetine Syrup, Inflasone, Berlosid, Licokalk, and Licodexon. The majority of revenue is derived from the Herbal Medicine & Supplement segment.
85GF Score
Get the complete analysis for ISX:SIDO
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SIDO has been successfully added to your 
